ロード中...
Early G2/M checkpoint failure as a molecular mechanism underlying etoposide-induced chromosomal aberrations
Topoisomerase II (Topo II) inhibitors are cell cycle–specific DNA-damaging agents and often correlate with secondary leukemia with chromosomal translocations involving the mixed-lineage leukemia/myeloid lymphoid leukemia (MLL) gene on chromosome 11 band q23 (11q23). In spite of the clinical importan...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
2006
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1312016/ https://ncbi.nlm.nih.gov/pubmed/16357944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI25716 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|